Tag - covid-19-variants

 
 

COVID 19 VARIANTS

Japan Times
WORLD
Feb 28, 2021
U.K.’s variant trackers led the way. Now others are following.
The COVID-19 Genomics U.K. Consortium has become a global model for analyzing genomes for signs that the coronavirus is gaining power to spread — or to kill.
Japan Times
JAPAN
Feb 19, 2021
COVID-19 cluster discovered at immigration facility as new strain spreads in Japan
The new variant, which features the so-called E484K mutation that may undermine vaccine effectiveness, has been identified in 93 cases in the nation.
Japan Times
WORLD
Feb 18, 2021
Pfizer says South African variant could significantly reduce vaccine protection
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc.-BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.
Japan Times
WORLD
Feb 8, 2021
U.K. plans annual vaccinations to fight new coronavirus strains
U.k. Health Minister Nadhim Zahawi has predicted annual vaccination drives similar to the program of injections given for influenza each year.
Japan Times
WORLD / Science & Health
Feb 7, 2021
Oxford-AstraZeneca COVID-19 shot less effective against South African variant, study says
British drugmaker AstraZeneca said on Saturday its vaccine developed with Oxford University appeared to offer only limited protection against mild disease caused by the South African variant of COVID-19, based on early data from a trial.
Japan Times
WORLD
Feb 2, 2021
Study shows COVID-19 variant spreading in Britain could become resistant to vaccines
Experiments in test tubes suggest that some of its mutations allow the coronavirus to hold onto cells more tightly.
Japan Times
WORLD
Jan 31, 2021
COVID-19 mutations undercut optimism even as more vaccines near
Mutations that likely confer partial resistance to vaccines and antibody treatments are now prevalent in both South Africa and Brazil, and they are threatening to spread worldwide.
Japan Times
WORLD
Jan 29, 2021
COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says
The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.
Japan Times
WORLD / FOCUS
Jan 29, 2021
Racing the virus: Why tweaking vaccines to fight variants won't be simple
After developing and rolling out COVID-19 vaccines at record speed, drugmakers are already facing variants of the rapidly-evolving coronavirus that may render them ineffective.
Japan Times
WORLD
Jan 26, 2021
As virus grows stealthier, vaccine makers reconsider battle plans
As the coronavirus assumes contagious new forms around the world, two drugmakers reported on Monday that their vaccines, while still effective, offer less protection against one variant and began revising plans to turn back an evolving pathogen that has killed more than 2 million people.
Japan Times
WORLD
Jan 23, 2021
New virus variant may be somewhat deadlier, U.K. warns
The evidence on the fatality rate is worrisome but not yet solid, scientists said. It contrasts with news that Britain is vaccinating its people at a promising pace.
Japan Times
WORLD / Science & Health
Jan 21, 2021
Emerging coronavirus variants may pose challenges to vaccines
Experts said it was possible that people who had survived mild infections with the coronavirus may still be vulnerable to infection with a new variant.
Japan Times
WORLD / Science & Health
Jan 19, 2021
Previous coronavirus infection may offer less protection from South Africa variant
Previous infection with the coronavirus may offer less protection against the new variant first identified in South Africa, scientists said on Monday, although they hope that vaccines will still work.
Japan Times
WORLD / Science & Health
Jan 19, 2021
Vaccine disparities raise alarm as coronavirus variants multiply
Global gaps in access to vaccines are raising concerns that the spread of the virus will breed more dangerous versions of the pathogen, weakening medical weapons.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?